The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Athena Philis-Tsimikas is Corporate Vice President of the Scripps Whittier Diabetes Institute at Scripps Health in San Diego, California, USA, and Associate Clinical Professor of Medicine at UCSD’s Division of Endocrinology and Metabolism. She leads the Scripps Diabetes Care Line, which creates programmes and delivers diabetes services across five Scripps hospitals, 25 outpatient facilities, and the community. Dr Philis-Tsimikas has devoted more than 20 years’ research and clinical efforts to improving diabetes assessment, education, and management.
Among other accomplishments, she developed and implemented the innovative Project Dulce programme, a collaboration between Scripps Health and San Diego area community clinics that emphasizes coordinated care management and relies on peer educators to deliver diabetes self-management education. She has also served as the Principal Investigator of numerous clinical trials.